[HTML] sciencedirect.com

[HTML][HTML] Kisspeptin as a new serum biomarker to discriminate miscarriage from viable intrauterine pregnancy

C Sullivan-Pyke, DJ Haisenleder, S Senapati… - Fertility and sterility, 2018 - Elsevier
Objective To validate the ability of serum kisspeptin-54 to discriminate between first-trimester
viable pregnancies and miscarriages. Design Case-control study. Setting Academic medical …
被引用次数：56 相关文章

Kisspeptin as a new serum biomarker to discriminate miscarriage from viable intrauterine pregnancy.

C Sullivan-Pyke, DJ Haisenleder, S Senapati… - Fertility and …, 2018 - europepmc.org
OBJECTIVE: To validate the ability of serum kisspeptin-54 to discriminate between first-
trimester viable pregnancies and miscarriages. DESIGN: Case-control study. SETTING …

Kisspeptin as a new serum biomarker to discriminate miscarriage from viable intrauterine pregnancy

C Sullivan-Pyke, DJ Haisenleder… - Fertility and …, 2018 - pubmed.ncbi.nlm.nih.gov
Objective To validate the ability of serum kisspeptin-54 to discriminate between first-trimester
viable pregnancies and miscarriages. Design Case-control study. Setting Academic medical …

Kisspeptin as a new serum biomarker to discriminate miscarriage from viable intrauterine pregnancy

C Sullivan-Pyke, DJ Haisenleder, S Senapati… - Fertility and …, 2018 - fertstert.org
Objective To validate the ability of serum kisspeptin-54 to discriminate between first-trimester
viable pregnancies and miscarriages. Design Case-control study. Setting Academic medical …
[HTML] nih.gov

[HTML][HTML] Kisspeptin as a New Serum Biomarker to Discriminate Miscarriage from Viable Intrauterine Pregnancy

C Sullivan-Pyke, DJ Haisenleder, S Senapati… - Fertility and …, 2018 - ncbi.nlm.nih.gov
Kisspeptin as a New Serum Biomarker to Discriminate Miscarriage from Viable Intrauterine
Pregnancy - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …